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Abstract: Osteoporosis is a prevalent bone condition, characterised by 
low bone mass and increased fracture risk. Currently, the gold standard 
for identifying osteoporosis and increased fracture risk is through 
quantification of bone mineral density (BMD) using dual energy X-ray 
absorption (DEXA). However, the risk of osteoporotic fracture is 
determined collectively by bone mass, architecture and physicochemistry 
of the mineral composite building blocks. Thus DEXA scans alone 
inevitably fail to fully discriminate individuals who will suffer a 
fragility fracture. This study examines trabecular bone at both 
ultrastructure and microarchitectural levels to provide a detailed 
material view of bone, and therefore provides a more comprehensive 
explanation of osteoporotic fracture risk. Physicochemical 
characterisation obtained through X-ray diffraction and infrared analysis 
indicated significant differences in apatite crystal chemistry and 
nanostructure between fracture and non-fracture groups. Further, this 
study, through considering the potential correlations between the 
chemical biomarkers and microarchitectural properties of trabecular bone, 
has investigated the relationship between bone mechanical properties 
(e.g. fragility) and physicochemical material features. 
 
 
 
 
Highlights 
 
 Physicochemical properties assessed through XRD and FTIR for non-fracture and 
fracture human specimens.  
 Significant differences in coherence length, ‘a’ axis lattice parameters and carbonate: 
phosphate ratios between the two groups.   
 With age, an increase in the phosphate to amide ratio and the coherence length was 
observed.  
 Correlations between mineral properties of bone at the ultrastructure level and the 
micro architectural properties of trabecular bone were observed.  
 
*Highlights (for review)
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Abstract  
Osteoporosis is a prevalent bone condition, characterised by low bone mass and increased 
fracture risk. Currently, the gold standard for identifying osteoporosis and increased fracture 
risk is through quantification of bone mineral density (BMD) using dual energy X-ray 
absorption (DEXA). However, the risk of osteoporotic fracture is determined collectively by 
bone mass, architecture and physicochemistry of the mineral composite building blocks. Thus 
DEXA scans alone inevitably fail to fully discriminate individuals who will suffer a fragility 
fracture. This study examines trabecular bone at both ultrastructure and microarchitectural 
levels to provide a detailed material view of bone, and therefore provides a more 
comprehensive explanation of osteoporotic fracture risk. Physicochemical characterisation 
obtained through X-ray diffraction and infrared analysis indicated significant differences in 
apatite crystal chemistry and nanostructure between fracture and non-fracture groups. 
Further, this study, through considering the potential correlations between the chemical 
biomarkers and microarchitectural properties of trabecular bone, has investigated the 
relationship between bone mechanical properties (e.g. fragility) and physicochemical material 
features.  
 
Keywords: aging, bone quality, hydroxyapatite, osteoporosis, trabecular bone, X-ray 
diffraction 
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Introduction  
Osteoporosis affects approximately 200 million women around the world. In the UK alone 
50% of women will suffer a fracture after the age of 50 [1], a rate which is annually 
increasing due to the aging population. Osteoporotic fractures often occur in the hip, wrist 
and vertebrae; although studies have shown hip fractures have the greatest detrimental effect 
on an individual [2]. Hip fractures result in a significant loss of independence, and sufferers 
are unable to live without support as they cannot walk unaided or perform many of their daily 
activities. Worryingly, hip fractures are often associated with increased mortality [3, 4], a 
statistic which is confounded by the asymptomatic nature of osteoporosis. Osteoporosis is 
often assessed according to an individual’s bone mineral density (BMD) [5]. With a decrease 
in BMD, the risk of fracture is significantly increased [6]. Currently the gold standard for 
measuring BMD is through the use of dual energy X-ray absorption (DEXA). Unfortunately 
DEXA is not without limitations and is arguably a poor predictor of fracture, with a study 
carried out by Wainwright et al.  showing that 54% of new hip fractures occurred in women 
who did not have osteoporosis as determined by their BMD [7] and data from the National 
Osteoporosis Risk Assessment, showed that 82% of post-menopausal women with fractures 
had bone of 'normal' BMD [8]. The limitation of DEXA was perhaps highlighted with the 
development of FRAX, the World Health Organisation (WHO) fracture assessment tool, 
which uses BMD along with clinical risk factors and country-specific fracture and mortality 
data to quantify a patient's 10-year probability of a hip or major osteoporotic fracture [9]. 
FRAX takes into account demographic information such as age, sex, a prior fracture, family 
history of fracture, and lifestyles risk factors such as physical inactivity and smoking.  
The limits associated with BMD to predict an individual patient’s fracture risk is arguably 
because it does not measure the multiple material factors that contribute to bone strength 
[10]. There are several complex determinants of bone strength and fragility, and although 
properties which may increase the resistance to one type of mechanical demand, for example 
static loading, may also be detrimental to other kinds such as fatigue loading [11]. For this 
reason, material scientists differentiate between stiffness: how well a material resists 
deformation, toughness: the ability of a material to absorb energy prior to failure and 
strength: the ability of a material to resist failure when stretched or compressed. In this 
manuscript, strength refers to the ability of the material to withstand loading before structural 
failure occurs. The assumption is that bone strength is lower for the fracture group than that 
of the non-fracture group. Further mechanical testing would be required to establish whether 
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bone chemistry parameters investigated in this study are independently correlated to stiffness, 
toughness or strength.  
In this context, bone strength is a combination of bone density as well as ‘bone quality’, 
whereby bone quality refers to bone architecture (i.e. macro and micro) and bone chemistry 
[10]. A small number of studies (possibly due to the difficulty of obtaining human bone, 
especially osteoporotic specimens) have shown microarchitectural properties of bone 
potentially offer a superior way to differentiate between diseased bone (due to osteoporosis or 
osteoarthritis) when compared to healthy controls [12 - 14]. This has recently led to the 
investigation of various imaging techniques including high-resolution peripheral quantitative 
computed tomography (HR-pQCT) and the development of analytical tools such as trabecular 
bone score (TBS). Unfortunately, HR-pQCT is restricted to peripheral skeletal sites and 
therefore the lumbar spine or proximal femur (common sites for osteoporotic fragility 
fractures which are associated with the most significant quality of life burden for patients) 
cannot be imaged with this technique [15]. TBS, which captures information relating to 
trabecular microarchitecture by performing novel grey-level texture measurements on DEXA 
images [16], is undoubtedly promising; however, this tool quantifies the micro architecture of 
the bone only and does not account for bone chemistry.  
Bone chemistry is more complex, with studies often providing contradicting results and 
conclusions [17 – 23]. Unfortunately, many of the studies which investigate the chemistry of 
osteoporotic bone are limited by relatively low sample numbers (n ≤ 10 for both osteoporotic 
and ‘normal’ specimens) [20, 24, 25] and/ or utilise ovariectomized (Ovx) animal models [26, 
27].  Exceptionally, a more recent study by Boskey [22], investigated the material properties 
of a large number of cortical and trabecular specimens (n = 120) using Fourier transform 
infrared spectroscopy (FTIR). The bone specimens were collected from the iliac crest (as a 
proxy for fractures at other sites) between 6 months and 5 years after a fracture. Several 
previous studies have examined the physicochemical properties of the inorganic bone 
component (i.e. the hydroxyapatite mineral) characterised by X-ray diffraction (XRD) [17, 
24, 25] and the organic component (i.e. collagen) as characterised by Raman spectroscopy 
[28, 29] or Fourier transform infra-red spectroscopy (FTIR) [26, 30 - 33].  Perhaps of most 
relevance are those reports detailing differences between osteoporotic and ‘normal’ tissues, 
although inconsistencies are frequent. For example, reports such as those of Thompson et al 
[17] and Faibish and Boskey [34] suggested an increase in crystallite size in osteoporotic 
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tissue. However, these two reports differ in conclusions regarding the crystal chemistry; 
Thompson suggested a decrease in carbonate [17], while Faibish and Boskey [34] argued for 
an increase when comparing osteoporotic to normal bone. An increase in both crystallite size 
and carbonate content was reported by Gadeleta et al [18]. Several reports have been unable 
to demonstrate significant differences between osteoporotic and normal bone tissue when 
considering crystallite size [20, 27, 35] although a review by Boskey in 2003 reported that the 
general consensus accepts that osteoporotic bone mineral has larger crystallites than the non-
osteoporotic counterparts [19]. It is evident from the literature this view point is contentious. 
A more recent study by Boskey et al. [22] reported a decrease in carbonate to phosphate 
ratios in fractured bone compared to non-fractured cortical bone, suggesting either a decrease 
in carbonate and/ or an increase in phosphate. No other differences were observed for either 
cortical or trabecular bone. In contrast, McCreadie et al. reported an increase in the carbonate 
to phosphate ratio between specimens collected from women with and without osteoporotic 
fractures [28].  
There have been a few studies that have examined changes to the hydroxyapatite unit cell 
parameters (as a proxy for lattice substitutional modifications) of osteoporotic and/or aged 
bone mineral [35, 36]. The major substitution in biological hydroxyapatite is carbonate, 
which substitutes for the hydroxyl (A – type) and/ or phosphate (B-type) in the crystal lattice 
or exists on the apatite surface (labile carbonate) [37, 38]. In general, a decrease in ‘a’ axis 
and an increase in the ‘c’ axis lattice parameters has been reported with age [36]. These 
trends are consistent with increased in B-type carbonate substitution [37] observed in 
synthetic apatites. In contrast other studies were unable to detect differences in the lattice 
parameters of osteoporotic bone [35]. As a further bone characteristic measured by FTIR, it 
has been reported that for osteoporotic tissues the mineral to organic ratio is lower than that 
of normal bone [18, 30]. Thus in general, the literature contains several previous studies of 
bone physicochemical characteristics but these very often provide apparently conflicting 
findings and results.   This, in the context of our work, is considered in further detail within 
our Discussion section. 
The study described herein reports the physicochemical properties assessed using XRD and 
FTIR for trabecular bone obtained from the femoral head of individuals who suffered a 
femoral neck fracture and from a corresponding group where no fracture was reported. 
Further to this investigation, the data provided an opportunity to explore relationships 
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between the ultrastructure material building blocks and the derived architectural properties. 
Thus the potential  relationship between the bone mineral chemical properties – and the micro 
architectural properties of bone was investigated. This novel component of the work only 
involved the fracture group as relatively large deviations in architecture would be expected in 
this group.  
Materials and Methods  
Bone Specimens  
A sample set of 20 femoral heads were collected from osteoporotic female patients who had 
suffered fragility fractures at the femoral neck and consequently required hip replacement 
surgery. Of these 20, the donor’s age was available for 16 of the femoral heads, ranging from 
59 – 91 years old. Ethical approval for the collection and use of these specimens was 
provided by Gloucestershire NHS trust REC. Non-fracture femoral head specimens were 
collected from 39 female donors within the Melbourne Femur Collection. All donors from 
this source were coronial cases and had therefore died suddenly and unexpectedly as result of 
accidents. Ethical approval for the collection and use of these specimens was provided by 
Melbourne University. Population characteristics for both fracture and non – fracture 
specimens are provided in Table 1.  
 
 
Age Matched 
(70 + years) 
 
Fracture 
Non-
Fracture 
Fracture 
Non-
Fracture 
p-value 
Donors 16 39 15 21  
Age Range (yrs) 59 - 91 20 – 90 73 – 90 71 - 90  
Age Mean (yrs) 82.4 ± 6.4 66.1 ± 17.9 82.5 ± 4.1 79.4 ± 5.4 0.064 
Weight Range (kg) 41 - 79 40 - 121 41 - 79 49 - 87  
Weight Mean (kg) 61.1 ± 8.9 66.7 ± 19.7 60.8 ± 9.1 63.69 ± 13.0 0.494 
Stature Range (cm) 155 - 173 145 - 169 155 - 173 146 - 169  
Stature Mean (cm) 163.9 ± 5.2 159.6 ± 6.7 164.3 ± 5.1 159.6 ± 7.1 0.060 
 
Table 1: Population characteristics for the fracture and non-fracture groups including 
characteristics once age matched (70 + years). The standard deviations for all mean values 
are provided. p – values are provided for comparison of the age matched data (age, weight 
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and stature) for the two groups. p – values were calculated using a t-test, with a confidence 
level of 95%, after assessing normality and differences in variances. Note weight and stature 
data was only available for n = 24 for all the non - fracture donors and n = 13 for the age 
matched non-fracture donors.  
 
Sample Preparation  
Trabecular bone was obtained and analysed for this study from the femoral head. Overall the 
strategy was to select random samples with respect to femoral head location although each 
sample was cut to include tissue from at least two quadrants of the head. The femoral head is 
often defined into four quadrants: anterior, posterior, inferior and superior [39, 40]. It is 
important to note that samples were obtained from trabecular bone only, and did not include 
cortical bone. For a complete description of the sampling and sectioning procedure refer to 
[41 - 43]. Prior to data collections, the specimens were homogenised using a Retsch mixer 
miller (mm 2000) and a zirconium oxide milling basket and ball. The specimens were cut into 
smaller sections, to reduce the number of milling cycles and milled for one minute. Once 
powdered, the specimens were sieved through a stainless steel mesh sieve of 106 μm to 
ensure a homogenous fine powder sample.      
 
X-ray diffraction (XRD)  
The powdered trabecular bone specimens were individually loaded on to low background 
scattering (off-cut silicon) XRD holders. The bone powder was spiked with a NIST standard 
reference silicon powder (640c) to provide an internal standard required for determining 
accurate lattice parameters. XRD analysis was carried out using a PANalytical X’Pert PRO 
Multi-Purpose Diffractometer with Cu Kα radiation. A PIXcel strip detector was used to 
collect data as stepped scans across an angular range of 15 – 80 2θ (o) (5.90 – 1.20 Å). The 
count time at each step was equivalent to ~ 1 second. Data was also collected for two further 
stepped scans under the sample conditions but across an angular range of 23 – 27 2θ (o) (3.86 
– 3.30 Å d-spacing) and 50 – 55 2θ (o) (1.82 – 1.67 Å d-spacing), and with a count time at 
each step equivalent to ~ 3 seconds. The two additional stepped scans were collected to 
provide greater quality data for the 002 and 004 Bragg maxima respectively. This data was 
used to accurately calculate the full width half maximum (FWHM) of both the 002 and 004 
Bragg maxima. The FWHM values were then used to calculate coherence length using the 
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Scherrer equation, as described below. Bruker Topas software (Version 4.1, 2008) was 
employed to undertake profile fitting of each diffraction profile. This provided quantitative 
crystallite size and morphology parameters through calculation of the coherence length and 
structural parameters of the crystal lattice through the lattice parameters.  
Coherence length was calculated for two orthogonal crystallographic directions, <00ℓ> and 
<0k0> using the Scherrer equation, which uses the instrument corrected, full width half 
maximum of the desired peak, as described in [44]. The lattice parameters were calculated 
from whole pattern fitting refinement of diffraction profiles to obtain the 2θ peak positions. 
Sample displacement was refined and lattice parameter data corrected accordingly.  No unit 
cell content model was applied and analytical peak shapes were pseudo-Voigt.  The data 
collection, correction and analyses were repeated three times for five randomly selected 
specimens to assess repeatability. 
 
Fourier Transform Infrared Spectroscopy (FTIR) 
FTIR analysis was carried out using an attenuated total reflectance (ATR) – FTIR. ATR-
FTIR reduces sample preparation as there is no requirement for preparation of potassium 
bromide (KBr) pellets and the bone powder can be examined directly. This reduces potential 
contamination. Although ATR spectra measured by FTIR are similar to those collected by 
transmission measurements it is worth noting there are subtle differences. This is due to the 
wavelength dependency of the penetration depth in the sample and the anomalous dispersion 
of the IR-light. Consequently in ATR, which is a surface analysis technique, IR absorbance 
bands at long wavelengths will be of higher absorbance than those of shorter wavelength.  
Approximately 2 mg of homogenised bone powder (~106 μm particle size) was used for 
analysis. Three x 2 mg of bone powder per specimen was analysed to assess repeatability. 
FTIR spectra were collected using a Bruker Alpha Platinum ATR and analysis carried out 
using PerkinElmer Spectrum software. A scan resolution of 4 cm
-1
 and 16 scans was 
employed for data collection, within a range of 2500 – 400 cm-1.   
FTIR analysis was employed to provide semi-quantitative data on the organic and carbonate 
content in the specimens. Following convention [45 - 48], the mineral: organic ratio was 
assessed through measuring the area of the v3 phosphate (1200 – 900 cm
-1
) and the amide I 
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(1750 – 1600 cm-1) bands. The carbonate: phosphate was assessed through measuring the 
area of the v2 carbonate (890 – 850 cm
-1
) and v3 phosphate bands.  
 
Micro Computed Tomography (µ - CT) 
The relationship between architectural properties and physicochemical parameters were 
investigated for this study. The architectural properties of the fracture specimens, obtained 
from µ- CT, have previously been reported, details of which can be found elsewhere [41]. 
Parameters such as trabecular number (TbN), structure model index (SMI), trabecular 
thickness (TbTh), bone volume to total volume (BV/ TV) and tissue mineral density (TMD) 
were previously reported. It is important to note that the same specimens quantified using µ- 
CT were pulverised once imaged and analysed for this study. Additional tissue from the same 
patient was not utilised.  
 
Statistical Analysis   
Linear regression analysis was carried out to statistically assess correlations between various 
material characteristics parameters and age for the non-fracture group. A general linear model 
ANOVA analysis was also undertaken to determine significant differences between the 
parameters measured for age matched fracture and non-fracture groups. Donors of age 70 
years and greater were utilised for quantitative comparisons between the two groups, to avoid 
any bias arising from differences in age distributions.  For the fracture group, n = 15, as one 
donor, a 59 year old, was excluded from the age matched statistical analysis. For the non – 
fracture group, n = 21 when age matching. p < 0.05 was considered statistically significant 
for both the linear regression and ANOVA analysis.  
 
Results 
This study reports the material quality of trabecular bone from human fracture and non – 
fracture specimens, with the parameters analysed correlated to age. Further, the material 
quality parameters associated with the fracture specimens have been correlated to the 
microarchitecture properties (previously reported in [41]). This provides a more 
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comprehensive understanding of how a change in the material chemistry can be associated 
with parameters such as trabecular number (TbN), tissue mineral density (TMD), structure 
model index (SMI) and bone volume to total volume (BV/TV). The average values and 
associated errors of the material properties derived from both XRD and FTIR analysis are 
presented in table 2, along with the p-values associated with age matched ANOVA analysis 
of fracture (n = 15) and non-fracture groups (n= 21).  
 
 
All Specimens Age Matched (70+ yrs) 
ANOVA 
Non - 
Fracture vs 
Fracture 
(Age 
Matched) 
 
Fracture 
Non – 
Fracture 
Fracture 
Non – 
Fracture 
p – value 
N 16 39 15 21 - 
CL 00ℓ (nm) 
27.5 
(0.6) 
28.9 
(0.3) 
27.4 
(0.4) 
28.8 
(0.4) 
0.020 
CL hk0 (nm) 
8.24 
(0.10) 
8.21 
(0.08) 
8.25 
(0.09) 
8.32 
(0.10) 
0.487 
LP ‘a’ axis (Å) 
9.402 
(0.001) 
9.406 
(0.001) 
9.403 
(0.001) 
9.407 
(0.001) 
0.002 
LP ‘c’ axis (Å) 
6.896 
(0.0006) 
6.895 
(0.002) 
6.897 
(0.0004) 
6.896 
(0.002) 
0.320 
Mineral: Organic 
7.10 
(0.08) 
7.06 
(0.08) 
7.02 
(0.03) 
7.23 
(0.09) 
0.077 
Carbonate: 
Phosphate 
0.0199 
(0.0004) 
0.0185 
(0.0002) 
0.0202 
(0.0003) 
0.0184 
(0.0003) 
0.000 
  
Table 2: Average values (in bold) and the associated errors (± SEM) in brackets for the 
material parameters obtained from XRD and FTIR analysis, for fracture and non-fracture 
groups. p – values for age matched ANOVA analysis of fracture (n = 15) and non-fracture 
groups (n= 21), for each material characteristic parameter are also provided.  
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X-ray Diffraction (XRD) 
Coherence length, which provides a quantitative estimate of crystallite size and strain 
combined (i.e. the total lattice disorder), did not change with age for the non – fracture group 
in the <00ℓ> crystallographic direction, but was found to increase (p = 0.016) with age when 
the <0k0> direction was considered (Figure 1A). The coherence length values for the fracture 
group were lower (p = 0.020) when age matched to the non – fracture group specimens in the 
<00ℓ> direction (see Table 2). With increasing age, the lattice parameters associated with the 
‘a’ axis and ‘c’ axis remain constant, within experimental errors, for the non – fracture group, 
ranging from approximately 9.40 – 9.41 Å for the ‘a’ axis (Figure 1B) and 6.85 – 6.90 Å  for 
the ‘c’ axis. The ‘a’ axis lattice parameter values for the fracture group are less (p = 0.002) 
than those of the non – fracture group (see Table 2). No difference in the ‘c’ axis lattice 
parameters were observed between the two groups.  
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Figure 1: Relationship between XRD parameters and age (A: coherence length (CL) values 
along the 00ℓ direction vs age, B: ‘a’ axis lattice parameters vs age), for fracture and non-
fracture specimens. Errors have been excluded from the graphs for clarity. Standard box and 
whisker plots for the age matched data (70 years +) are included as inserts in each graph. The 
horizontal line within the box indicates the median, boundaries of the box indicate the 25
th
 
and 75
th
 percentile, and the whiskers indicate the highest and lowest values of the results. The 
‘◊’ marked in the box indicates the mean.  
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Table 3: p – values and R2 calculated from linear regression statistical analysis when 
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group. For the parameters were a significant trend was observed, the rate of change (∆) per 5 
years is also reported. Associated errors are provided in brackets.  
 
Fourier Transform Infrared Spectroscopy (FTIR) 
The carbonate to phosphate ratio was found to be greater (p = 0.000) for the fracture group in 
comparison to the non-fracture group, when age matched.  No age related trends were 
observed for the non – fracture group (Figure 2A). The value of the mineral to organic ratio, 
which indicate an increase in collagen and/ or a reduction in phosphate, are presented in 
figure 2B for both fracture and non – fracture groups. The variability in the mineral to 
organic ratio for the non – fracture group is evident. When age matched, the mineral: organic 
values are not different (p = 0.077) for the fracture group in comparison to the non – fracture 
group. However, with age, an increase in mineral to organic ratio values was observed (p = 
0.019) for the non-fracture group. 
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Figure 2: Relationship between FTIR parameters and age (A: carbonate: phosphate values vs 
age, B: Mineral: organic values vs age), for fracture and non-fracture specimens. Errors have 
been excluded from the graphs for clarity. Standard box and whisker plots for the age 
matched data (70 years +) are included as inserts in each graph. The horizontal line within the 
box indicates the median, boundaries of the box indicate the 25
th
 and 75
th
 percentile, and the 
whiskers indicate the highest and lowest values of the results. The ‘◊’ marked in the box 
indicates the mean. 
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Table 4: p – values and R2 calculated from linear regression statistical analysis when 
comparing the various FTIR material characteristic parameters and age for the non-fracture 
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Microarchitecture and Material Characteristics 
We have also examined correlations between the material properties and the architectural 
properties for the fracture group, in order to explore the potential influence bone chemistry 
may have on the architecture of compromised specimens. There is significant evidence from 
previous studies that bone mechanical properties (e.g. fragility) are affected by 
physicochemical material features [18, 49 - 53], although there remains controversy 
concerning the precise nature and magnitude of such relationships. The composition of 
apatite is known to markedly affect its crystallite size and shape. For example phosphate 
substitution by carbonate (bone apatite contains ~5 % wt. CO3
2-
) results in smaller crystallites 
than the corresponding unsubstituted chemistry [54, 55], as the increase in lattice disorder 
produces increased solubility of the crystallites [55, 56].     
 
Coherence length  
<00ℓ> coherence length values were found to correlate with various microarchitecture 
parameters previously reported for the fracture group (Figure 3). With increasing coherence 
length values, an increase in trabecular thickness (TbTh) (p = 0.028, R
2
 = 0.24, Figure 3A), 
tissue mineral density (TMD) (p = 0.006, R
2
 = 0.35, Figure 3B) and bone volume to total 
volume (BV/TV) (p = 0.036, R
2
 = 0.22).  
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Figure 3: Relationship between microarchitecture properties and coherence length (00ℓ 
direction), for fracture specimens, A: TbTh vs CL, B: TMD vs CL. Errors have been 
excluded from the graphs for clarity. 
 
Discussion  
Although bone performs biologically critical mechanical and homeostatic functions [57], the 
relationships between its hierarchical constituents are not well understood. The basic 
chemical composition (non-stoichiometric hydroxyapatite), crystallises into a variable ultra-
structure (nano-crystallites) that together with organic components form the fundamental 
building blocks of bones microarchitecture. Thus, in order to understand mechanical failures 
associated with compromised bone tissue such as osteoporotic material, it is crucial to 
understand the fundamental chemistry of the biological mineral.  
In contrast to previous studies where the osteoporotic stage of the bone is unknown (e.g. 
Ovx) [18, 27, 58], our specimens have fractured and therefore present particularly 
compromised material. Further the power of some previous studies [20, 24, 35] may be 
insufficient to demonstrate the significant differences observed within our work.  
It is important to note here that some of the fundamental mechanical properties of bone may 
be due to natural engineering processes and cannot be attributed to osteoporosis solely. For 
example, pre-stressed material components are found within bone and teeth. These stresses 
not only allow for the structure of bone to perform in its preferred mode of loading [59], but 
also protect the microstructure from cracking [60]. Collagen dehydration upon mineralisation 
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has been found to be at the origin of the compressive pre-strains commonly observed in bone 
mineral [61]. This creates tension within the collagen fibrils, which has been proposed to 
offer additional protection against fibril buckling under compression, reducing the danger of 
bending the fibres, which would lead to fracture [60].  
Current literature focuses on the microarchitecture of bone [12 – 14], but few studies have 
investigated the material crystallographic characteristics of compromised bone mineral [17 – 
21, 24]. The potential relationship between parameters at the nanoscale (i.e. in the mineral 
chemistry) and the microarchitecture parameters of human bone has, to the authors’ 
knowledge, not previously been directly considered. X-ray coherent scatter provides 
information specifically regarding the physicochemical characteristics of bone mineral. 
Differences in the material properties between osteoporotic and ‘normal’ material, 
particularly derived from X-ray diffraction, are not consistent across the literature [17, 24, 27, 
35, 36].  
 
XRD: Crystallinity 
The absolute values for coherence length from this study are consistent with previously 
published examinations of human bone [35, 62, 63].  We were unable to detect changes in 
<00ℓ> coherence length or lattice parameters with age. A previous study of Handschin and 
Stern [64] reported an increase in crystal length up to the age of 25 years old and no 
significant changes until the age of 50 years old, whereupon the average length decreased. 
The observed changes at 25 years and 50 years old may not have been apparent in the data 
presented in our study due to limited power. Handschin and Stern utilised a greater number of 
specimens (n = 117), across a wider age range (0 – 90 years old). An increase in coherence 
length along the <0k0> direction, which suggests an increase in crystallite size and a decrease 
in lattice disorder, was observed with age in the study reported here.    
When age matched, significant differences between fracture and non-fracture material were 
demonstrated.  The <00ℓ> coherence length was found to be lower for the fracture group than 
the non- fracture group (p = 0.020). This is surprising and counter to previous FTIR studies 
[18, 34]. However, a possible mechanism to consolidate our view with others is to consider 
that in OP apatite the carbonate ions preferentially replace those phosphate ions within the 
most shallow potential wells i.e. those most disordered and measured through the 1020 cm
-1
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IR band, thus causing an apparent increase in crystallinity as measured through the IR 
crystallinity index (1030/ 1020). The X-ray diffraction coherence length is consequently 
reduced, and thus the crystallinity appears to decrease. This is further corroborated by a 
reduction in the ‘a’ axis lattice parameter.   
Our study therefore suggests a smaller coherence length corresponds to a material which is 
more susceptible to fracture, suggesting the mechanical strength would be less than that of 
non-fractured material. Previous studies have suggested that crystal size is related to 
mechanical strength [65 - 67], and that increased bone mineral crystal size is associated with 
increased bone fragility [65]. However, after reporting a decrease in crystal thickness with 
age as crystal length increases, Boskey and Mendelson suggested from their preliminary data 
that mechanical strength is greater when the average crystallinity is greater [68]. Boskey also 
argued in favour of an optimal situation in which there is a broad distribution of crystal sizes 
[19] and Fonseca et al. reported that bone strength is favoured by greater mineral crystal size 
heterogeneity [11]. Further, Chachra et al. [69] reported that a reduction in crystallite size of 
bone mineral is associated with a decreased load accommodation and increased fracture risk. 
This is has also been observed in pathologies such as osteogenesis imperfecta
 
[70].  
 
XRD: Lattice substitutions 
The lattice parameters reported herein are significantly less than those reported previously 
[35, 36]. For this study, an internal reference in the form of silicon was employed to ensure 
accuracy and our values are consistent with levels of carbonate substitution known to occur in 
bone [37]. Precision was crucial in this study as differences between fracture and non-fracture 
material were anticipated to be subtle.  As previous studies do not use internal references, this 
could explain the difference in absolute values, although it is possible that other differences 
such as particle size, tissue source and prior treatment of specimens may also contribute to 
inter-study inconsistencies with respect to lattice parameters.   
The ‘a’ axis lattice parameter values, which are rarely reported in the literature for bone 
material, were found to be lower (p = 0.002) for the fracture group in comparison to the non-
fracture group. In contrast, Mkukuma et al reported no difference between osteoporotic 
material and ‘normal’ tissue when considering lattice parameters [35]. However, the relative 
low power (low sample numbers) may not have revealed the relatively modest differences (< 
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1%) between osteoporotic and ‘normal’ tissue. The stoichiometric ‘a’ axis lattice parameter 
value for hydroxyapatite is reported as 9.42 Å [36]. The data reported herein suggests non-
fracture material is more stoichiometric than the fracture material, and therefore more 
chemically stable. Changes to lattice parameters values are caused by ionic exchanges and 
vacancies which induce strain into the lattice. This changes the characteristics of the apatite 
which are critical to crystallite size and dissolution rate [71]. Greater dissolution rates, for 
example, will be observed for mineral lattices which are highly strained and therefore less 
stoichiometric. As osteoporosis is a condition associated with bone loss and perhaps greater 
turnover, the more soluble lattice structure is probably a more likely state for the mineral 
being formed. The reduced lattice parameters calculated for the fracture group is consistent 
with the carbonate to phosphate ratios calculated with FTIR, as many studies have shown 
with increasing B –type carbonate, the ‘a’ axis lattice parameter is reduced [37, 72]. No 
difference was observed for the ‘c’ axis lattice parameters between the two groups. Changes 
to the unit cell through ionic substitutions has previously been shown to have more of an 
effect on the ‘a’ axis in comparison to the ‘c’ axis [37], which is evident when considering 
the influence of carbonate substitute on the lattice parameters. LeGeros reported a systematic 
change in ‘a’ that was 2.5 times that of ‘c’ for an equivalent increase in amount of B-type 
carbonate substitution [37]. Therefore we propose that the sensitivity of our study is too low 
to detect corresponding significant changes to the ‘c’ axis. 
 
FTIR 
The material characteristics obtained from FTIR demonstrate an increase in the mineral to 
organic ratio with increasing age. This may suggest an increase in the amount of phosphate 
and/or a decrease in collagen (measured through the amide vibrational peak). An increase in 
mineral content with age has previously been reported [19], as well as a decrease in collagen 
content [73]. When age matched, the mineral to organic ratio was not significantly different 
between the fracture and non-fracture group, although the values for the fracture group were 
lower.  In contrast, previous studies have shown a decrease in the mineral to organic ratio in 
ovariectomized animal and osteoporotic human tissue [18, 30, 33, 45, 74], suggesting either a 
lower mineral content and/ or a greater collagen content.  The consensus tends to be that in 
osteoporotic bone, a decrease in mineral content is observed [18, 19], resulting in a reduction 
in mechanical strength [11]. 
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Although carbonate incorporation has been reported to increase [64, 75, 76] and decrease [45, 
77] with age, no correlation with age was observed for the carbonate to phosphate ratio 
values in this study. This is consistent with [66], who found carbonate incorporation 
remained constant after 45 years old. When age matched, a mean difference of 0.002 ± 
0.0004 was observed for the carbonate to phosphate ratios between the two groups. The 
average value for the fracture group was greater in comparison to the non-fracture group ( p = 
0.000). This suggests greater carbonate content in the fracture material in comparison to the 
non-fracture material and/ or less phosphate. A higher carbonate to phosphate ratio in the 
fracture material is consistent with previous studies [18, 28, 34]. This increase is consistent 
with the data reported here, where a ~ 11% increase in the carbonate to phosphate ratio was 
observed for the fracture material.  
In general, it is considered that newer bone contains a large quantity of carbonate and is 
characterised by smaller crystals [38, 78]. In an accelerated turnover system, the consumption 
rate of the more mature tissue (i.e. that preferentially targeted for remodelling) is enhanced 
[79].  Crystallite populations then become biased towards reduced average dimensions, larger 
specific surface areas and greater amounts of carbonate. The data presented here is consistent 
with this model, as the coherence length values are lower for the fracture material whilst the 
carbonate to phosphate ratio was greater. 
 
Evaluation 
The results from this study must be seen in the context of previous work and some 
speculation offered for apparent inconsistencies. There is clear evidence of significant 
differences in the physicochemical characteristics of bone mineral from different sample 
sites. For example, Gourion‐Arsiquaud et al. reported greater cortical mineral/organic and 
trabecular crystallinity values associated with increased fracture risk when iliac crest 
specimens were analysed [32]. However, more recently, when investigating material 
properties of femoral neck specimens, a decrease in the mineral: organic ratio for both 
cortical and trabecular fractured bone was observed whilst no change in crystallinity was 
reported [33] by the same research group. Such differences can also be found between local 
geographic anatomies as demonstrated by Donnelly et al. [80]. Thus, it may be inappropriate 
to directly compare our findings with those from studies employing femoral neck and iliac 
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crest tissues as the physicochemical nature of the materials from different sites appear 
significantly different.   
Specific analytical differences may also compromise direct comparisons with other studies 
(and between previous studies). In particular, when considering determinations of 
‘crystallinity’, estimates derived from FTIR and those from XRD may superficially appear to 
be inconsistent.  FTIR methods determine crystallinity specifically from quantification of PO4 
site disorder averaged over all crystallographic directions. In contrast, our diffraction based 
crystallinity measurement is fundamentally different in that it is confined to disorder within 
one crystallographic direction and concerns all phenomena that reduce disorder in this 
direction [81]. A comparison between spectroscopic and diffraction estimates of crystallinity 
within biological apatites has previously highlighted inconsistencies between the results of 
the two approaches [82]. Thus at least for this parameter, direct comparisons between 
previously FTIR studies and ours may not be appropriate. For this and other characteristics, 
apparent inconsistencies between previous work and ours may also be partly as a result of 
sample preparation and sampling differences. Processing involving aqueous solutions has 
been shown to modify the physicochemical characteristics of bone [83-85] although in our 
study the tissues were frozen. Our approach of quadrant sampling randomisation would have 
increased the variability in any of the characteristics measured and thus, given the previously 
reported variation between quadrant values [33], we may have expected a reduction in the 
power of our experiments.    
 
Architecture 
This study has also examined relationships between the material characteristics of bone and 
its corresponding architectural properties, as there is significant evidence from previous 
studies that bone mechanical properties (e.g. fragility) are affected by physicochemical 
material features [18, 49 – 53, 65 – 68]. In this work, the bone mineral chemical parameters 
have been compared and the study provides a novel materials science insight into the 
relationship between bone physicochemistry at the nanoscale and the architecture of the bone 
at the microscale. The results suggest that there is a relationship between the material 
characteristics (in particular the coherence length) and the microarchitecture properties. 
Coherence length values are a quantification of crystallite disorder (size and microstrain). An 
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increase in microstrain can indicate ionic substitutions and vacancies. This change can also 
have an effect on crystallite dimensions and other factors including solubility. Previous 
studies have shown the solubility of apatite increases as the lattice microstrain is increased 
[71]. Further, disorder within the apatite lattice, has been proposed as a fundamental 
contributor to bone mechanical compromise for more than three decades
 
[65]. In this study, 
with increasing coherence length values, increases in TbTh, TMD and BV/TV were 
observed. It is proposed that bone apatite with higher coherence length values represents a 
more stable, less soluble material and therefore should be associated with increased amounts 
of bone mineral as reflected by the increase BV/TV, BMD and TbTh.  
 
Conclusion  
The principal main aim of this study was to investigate bone ‘quality’ in terms of mineral 
chemistry and organic content of fractured and non-fractured human material. Age related 
changes for the non-fracture material were also investigated.  The relationship between the 
bone mineral chemical characteristics and the microarchitecture parameters was also 
examined. As shown through statistical analysis, the coherence length (<00ℓ>), ‘a’ axis 
lattice parameters and carbonate to phosphate ratio values (when age matched) were different 
between fracture and non-fracture material from female donors. The study has also shown an 
increase in crystallite size and an decrease in lattice disorder ([0k0]) as well as an increase in 
the amount of phosphate and/or a decrease in collagen occurs with age for non-fracture 
material. It is proposed the data reported here suggests osteoporosis may not simply be an 
accelerated aging process when considering mineral chemistry and organic content, but there 
are fundamental chemical differences between fracture and non-fracture material not found 
with age. It is interesting to speculate that there may be a relationship between the mineral 
properties of bone at the ultrastructure level and the microarchitectural properties of 
trabecular bone.  
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